NCT04910256View on ClinicalTrials.gov

Clinical Study on Huatuo Zaizao Pills for Post-stroke Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

June 20, 2023

Study Completion Date

September 30, 2023

Conditions
Ischemic Stroke
Interventions
DRUG

Huatuo Zaizao Pills

Patients take 8g of HuaTuo Zaizao pill three times a day. Treatment lasts for 12 weeks.

OTHER

Basic treatment

"It accordance with the Guidelines for diagnosis and treatment of ischemic stroke in China,and the drug and dosage will be formulated by the researchers according to the clinical situation."

Trial Locations (1)

10091

Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing

All Listed Sponsors
lead

Xiyuan Hospital of China Academy of Chinese Medical Sciences

OTHER